"CD248" Related Products

Expand
Expand
Expand

Recombinant Human CD248 Protein, His-tagged

Cat.No. : CD248-23H
Product Overview : Recombinant Human CD248(Gln18-Arg685) fused with His tag at C-terminal was expressed in NS0.
Source : NS0
Species : Human
Tag : His
Predicted N Terminal : Gln18 predicted: No results obtained, sequencing might be blocked
Form : Lyophilized from a 0.2 μm filtered solution in PBS.
Bio-activity : Measured by its binding ability in a functional ELISA. When Recombinant Human Endosialin/CD248 is immobilized at 2 μg/mL (100 μL/well), the concentration of Recombinant Human Galectin‑3BP/MAC‑2BP that produces 50% of the optimal binding response is approximately 0.08-0.4 μg/mL.
Molecular Mass : Predicted Molecular Mass: 72 kDa;
SDS-PAGE: 110-150 kDa, reducing conditions.
Protein length : Gln18-Arg685
Endotoxin : <0.10 EU per 1 μg of the protein by the LAL method.
Purity : >95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Storage : Avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution : Reconstitute at 100 μg/mL in PBS.
Gene Name : CD248 CD248 molecule, endosialin [ Homo sapiens ]
Official Symbol : CD248
Synonyms : CD248; CD248 molecule, endosialin; CD164 sialomucin like 1 , CD164L1, CD248 antigen, endosialin; endosialin; TEM1; tumor endothelial marker 1; 2610111G01Rik; CD164 sialomucin-like 1; CD248 antigen, endosialin; CD164L1; MGC119478; MGC119479;
Gene ID : 57124
mRNA Refseq : NM_020404
Protein Refseq : NP_065137
MIM : 606064
UniProt ID : Q9HCU0

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.